Health Care: Drugs

Eli Lilly and Co (LLY: NYSE)

$83.56 -0.72 | -0.85%
06/27/17 - 10:01 AM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 21.22B 19.96B 19.62B 23.11B
Cost of Sales 4.16B 3.61B 3.55B 3.46B
Gross Operating Profit 17.06B 16.35B 16.06B 19.65B
Selling, General, and Administrative Expenses 6.45B 6.53B 6.62B 7.13B
Research & Development 5.27B 5.33B 4.93B 5.59B
Operating Income before D & A (EBITDA) 5.34B 4.48B 4.51B 6.94B
Depreciation & Amortization 1.50B 1.43B 1.38B 1.45B
Interest Income 108.70M 87.00M 121.00M 0.00
Other Income - Net -390.80M -192.90M -100.40M 398.30M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 3.56B 2.95B 3.15B 5.89B
Interest Expense 185.20M 161.20M 148.80M 0.00
Pre-Tax Income 3.37B 2.79B 3.00B 5.89B
Income Taxes 636.40M 381.60M 609.80M 1.20B
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 2.74B 2.41B 2.39B 4.68B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.74B 2.41B 2.39B 4.68B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.74B 2.41B 2.39B 4.68B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.74B 2.41B 2.39B 4.68B
Preferred Dividends
Net Income Available To Common 2.74B 2.41B 2.39B 4.68B
Basic EPS from Continuing Ops. 2.59 2.27 2.23 4.33
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.59 2.27 2.23 4.33
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.59 2.27 2.23 4.33
Basic Normalized Net Income/Share 2.59 2.27 2.23 4.33
EPS fr Continuing Ops. 2.58 2.26 2.23 4.32
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.58 2.26 2.23 4.32
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.58 2.26 2.23 4.32
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.58 2.26 2.23 4.32
Dividends Paid per Share 2.04 2.00 1.96 1.96

Portfolios with LLY

Latest LLY Headlines from TheStreet

More Financial News for LLY

Press Releases for LLY

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter